ロード中...
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
BACKGROUND: Shigellosis is a major cause of moderate to severe diarrhoea and dysentery in children under 5 years of age in low and middle-income countries. The Flexyn2a vaccine conjugates the O-polysaccharide of Shigella flexneri 2a to Pseudomonas aeruginosa exotoxin A. We describe a Phase 2b proof-...
保存先:
| 出版年: | EBioMedicine |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054157/ https://ncbi.nlm.nih.gov/pubmed/33862589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2021.103310 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|